Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Combining Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

NCT02642809 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02642809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02642809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Combining Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
June 8, 2016
Completion date
August 3, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the esophagus, esophageal cancer